Rici Healthcare Holdings (HKG:1526) Full Year 2024 Results
Key Financial Results
- Revenue: CN¥2.92b (down 2.3% from FY 2023).
- Net income: CN¥297.3m (down 18% from FY 2023).
- Profit margin: 10% (down from 12% in FY 2023).
- EPS: CN¥0.19 (down from CN¥0.23 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
The primary driver behind last 12 months revenue was the Medical Examination Centers segment contributing a total revenue of CN¥2.36b (81% of total revenue). Notably, cost of sales worth CN¥1.76b amounted to 60% of total revenue thereby underscoring the impact on earnings. The most substantial expense, totaling CN¥329.7m were related to Non-Operating costs. This indicates that a significant portion of the company's costs is related to non-core activities. Explore how 1526's revenue and expenses shape its earnings.
Rici Healthcare Holdings shares are down 10.0% from a week ago.
Balance Sheet Analysis
Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on Rici Healthcare Holdings' balance sheet.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.